Nantahala Capital Management »

Vaxcyte shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 35k 46.14

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Peloton Interactive Cl A Com (PTON)
Ban (TBBK)
Establishment Labs Holdings Ord (ESTA)
Viatris Call Option (VTRS)
Xtant Med Hldgs Com New (XTNT)
Spdr Series Trust State Street Spd Put Option (XBI)
Fulcrum Therapeutics (FULC)
Bioventus Com Cl A (BVS)
Savara (SVRA)

View all positions for Nantahala Capital Management

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Kynam Capital Management
Geode Capital Management
Caligan Partners

View all funds holding Vaxcyte